세계의 콜레스테롤 검사 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품 유형별, 검사 유형별, 처방 형태별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Cholesterol Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Test Type, By Prescription Mode, By End User, By Region & Competition, 2020-2030F
상품코드:1785186
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 콜레스테롤 검사 시장 규모는 2024년에 123억 6,000만 달러로 평가되었고 2030년까지 연평균 복합 성장률(CAGR)은 6.92%를 나타내 예측 기간 동안 견조한 성장이 예상되고 있습니다.
콜레스테롤 검사는 지질 프로파일 또는 지질 패널이라고도 불리며 혈액의 다양한 지질(주로 콜레스테롤과 트리글리세라이드)의 수준을 평가하는 데 사용되는 중요한 검사입니다. 이 검사는 일반적으로 총 콜레스테롤, 낮은 비중 지단백(LDL 또는 "나쁜"콜레스테롤), 높은 비중 지단백(HDL 또는 "좋은"콜레스테롤) 및 트리글리세리드를 측정합니다. 이 값은 심장혈관의 건강 상태를 파악하는 데 필수적이며 관상 동맥 질환, 심장 마비, 뇌졸중과 같은 잠재적 위험을 확인하는 데 도움이 됩니다. LDL 값이 높고 HDL 값이 낮 으면 동맥에 플라크가 축적되어 혈류가 제한되어 심각한 심장 합병증을 일으킬 위험이 높아집니다. 정기적인 콜레스테롤 검사는 심장병의 가족력이있는 사람, 당뇨병이있는 사람, 앉아있는 삶에서 식생활이 혼란 한 사람들에게 특히 중요합니다. 콜레스테롤 수치의 이상을 조기에 발견함으로써, 보다 건강한 식생활, 운동량 증가, 콜레스테롤 저하약의 사용 등, 생활 습관의 개선이나 의학적 개입을 적시에 실시할 수 있습니다. 콜레스테롤 수치는 연령, 유전, 식사, 건강 상태 등 다양한 요인에 영향을 받기 때문에 의료 전문가와 상담하는 것이 중요합니다. 의료 전문가는 결과를 정확하게 해석하고, 콜레스테롤을 관리하며, 장기적인 심혈관 건강을 유지하기 위한 개별 전략을 권장할 수 있습니다.
Global Cholesterol Testing Market was valued at USD 12.36 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 6.92% through 2030. A cholesterol test, also known as a lipid profile or lipid panel, is a vital medical examination used to assess the levels of various lipids-primarily cholesterol and triglycerides-in the bloodstream. This test typically measures total cholesterol, low-density lipoprotein (LDL or "bad" cholesterol), high-density lipoprotein (HDL or "good" cholesterol), and triglycerides. These values offer essential insights into a person's cardiovascular health and help identify potential risks for conditions such as coronary artery disease, heart attacks, and strokes. Elevated LDL levels and low HDL levels can increase the risk of plaque buildup in arteries, leading to restricted blood flow and serious heart complications. Routine cholesterol testing is particularly important for individuals with a family history of heart disease, those with diabetes, or people leading sedentary lifestyles with poor dietary habits. Early detection of abnormal cholesterol levels allows for timely lifestyle changes or medical interventions, such as adopting a healthier diet, increasing physical activity, or using cholesterol-lowering medications. Since cholesterol levels can be influenced by various factors-including age, genetics, diet, and overall health-it is essential to consult with a healthcare professional. They can interpret the results accurately and recommend personalized strategies for managing cholesterol and maintaining long-term cardiovascular wellness.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 12.36 Billion
Market Size 2030
USD 18.32 Billion
CAGR 2025-2030
6.92%
Fastest Growing Segment
Test Kits
Largest Market
North America
Key Market Drivers
Rising Prevalence of Cardiovascular Diseases
Cardiovascular diseases, including heart attacks and strokes, often have subtle or asymptomatic early stages. For instance, according to a 2024 article, coronary artery disease (CAD) is a common yet serious heart condition that can lead to heart attacks. A recent study, published in the European Heart Journal, highlights that measuring apolipoprotein B particles and lipoprotein(a) levels may improve risk prediction for CAD. These lipoproteins carry "bad" cholesterol in the blood and play a critical role in plaque buildup in coronary arteries. The Centers for Disease Control and Prevention (CDC) states that CAD is caused by plaque accumulation in the arteries supplying blood to the heart, emphasizing the importance of early screening and preventive care. Cholesterol testing helps identify individuals with high cholesterol levels, who are at an increased risk of developing CVDs. Early detection allows for timely intervention and lifestyle changes that can help prevent or manage the progression of these diseases. Cholesterol testing provides valuable information for risk assessment and stratification. Individuals with elevated cholesterol levels are categorized as high-risk patients for CVDs. This categorization helps healthcare providers tailor treatment and management strategies, potentially preventing future cardiovascular events. For individuals diagnosed with CVDs or at risk of developing them, cholesterol testing is used to monitor the effectiveness of treatments such as medication, dietary changes, and exercise. Regular testing helps healthcare professionals adjust treatment plans as needed to achieve target cholesterol levels. The rising prevalence of cardiovascular diseases underscores the importance of cholesterol testing as a critical tool for prevention, early detection, and management. The increasing demand for cholesterol testing is a natural response to the need to address the growing burden of CVDs and their associated risk factors.
Key Market Challenges
Technological Limitations
While point-of-care testing devices and home testing kits have improved accessibility, their accuracy might not always match that of laboratory-based testing, potentially affecting diagnostic reliability. Point-of-care testing devices and home testing kits might yield results that can vary from one test to another or from laboratory-based measurements. This variability can lead to uncertainty in interpreting results and making clinical decisions. Home testing kits and point-of-care devices rely on individuals performing the test correctly. User errors, such as improper sample collection or incorrect device operation, can significantly impact the accuracy of results. Proper calibration and maintenance of testing devices are crucial for accuracy. Without regular calibration and quality control, point-of-care devices might drift from accurate results over time. Inaccurate results from point-of-care testing or home testing kits can impact clinical decision-making. Incorrect management strategies based on unreliable results might harm patient outcomes.
Key Market Trends
Personalized Medicine
The trend toward personalized medicine will likely extend to cardiovascular health. Cholesterol testing can provide essential data for tailoring interventions and treatment plans based on an individual's unique risk profile. The trend toward personalized medicine has the potential to greatly impact cardiovascular health, and cholesterol testing plays a vital role in this shift. Personalized medicine aims to provide individualized healthcare based on an individual's unique genetic makeup, lifestyle, and other factors. Cholesterol testing offers essential data that can help tailor interventions and treatment plans specifically for an individual's risk profile. Based on an individual's cholesterol levels, genetic factors, medical history, and other health metrics, healthcare providers can create personalized treatment plans. This might involve lifestyle modifications, medication choices, and specific targets for cholesterol levels. Personalized medicine involves continuous monitoring of an individual's health markers. Cholesterol testing serves as a valuable tool for tracking progress and ensuring that the chosen interventions are effective. Regular testing encourages patient adherence to treatment plans. For individuals who require cholesterol-lowering medications, personalized medicine can guide the choice of medications and dosages. Certain medications might be more effective or better tolerated based on an individual's genetic and metabolic factors.
Key Market Players
Abbott Laboratories Inc.
Beckman Coulter Inc.
Horiba Ltd.
Nova Biomedical
Roche Holding Ag (F.Hoffmann-La Roche Ltd.)
Randox Laboratories Ltd.
Siemens Healthineers Gmbh
Sekisui Diagnostics LLC
Sinocare Inc.
Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Cholesterol Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cholesterol Testing Market, By Product Type:
Test Kits
Test Strips
Other
Cholesterol Testing Market, By Test Type:
Total Cholesterol Test
High-Density Lipoprotein (HDL) Cholesterol
Low-Density Lipoprotein (LDL) Cholesterol
Triglycerides/VLDL Cholesterol Test
Cholesterol Testing Market, By Prescription Mode:
Over the Counter
Prescription Based
Cholesterol Testing Market, By End User:
Hospitals & Clinics
Diagnostic Laboratories
Others
Cholesterol Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cholesterol Testing Market.
Available Customizations:
Global Cholesterol Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cholesterol Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type Type (Test Kits, Test Strips, Others)
5.2.2. By Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides/VLDL Cholesterol Test)
5.2.3. By Prescription Mode (Over the Counter, Prescription Based)
5.2.4. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Cholesterol Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Test Type
6.2.3. By Prescription Mode
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Cholesterol Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Test Type
6.3.1.2.3. By Prescription Mode
6.3.1.2.4. By End User
6.3.2. Canada Cholesterol Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Test Type
6.3.2.2.3. By Prescription Mode
6.3.2.2.4. By End User
6.3.3. Mexico Cholesterol Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Test Type
6.3.3.2.3. By Prescription Mode
6.3.3.2.4. By End User
7. Europe Cholesterol Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Test Type
7.2.3. By Prescription Mode
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cholesterol Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Test Type
7.3.1.2.3. By Prescription Mode
7.3.1.2.4. By End User
7.3.2. United Kingdom Cholesterol Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Test Type
7.3.2.2.3. By Prescription Mode
7.3.2.2.4. By End User
7.3.3. Italy Cholesterol Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Test Type
7.3.3.2.3. By Prescription Mode
7.3.3.2.4. By End User
7.3.4. France Cholesterol Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Test Type
7.3.4.2.3. By Prescription Mode
7.3.4.2.4. By End User
7.3.5. Spain Cholesterol Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Test Type
7.3.5.2.3. By Prescription Mode
7.3.5.2.4. By End User
8. Asia-Pacific Cholesterol Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Test Type
8.2.3. By Prescription Mode
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cholesterol Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Test Type
8.3.1.2.3. By Prescription Mode
8.3.1.2.4. By End User
8.3.2. India Cholesterol Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Test Type
8.3.2.2.3. By Prescription Mode
8.3.2.2.4. By End User
8.3.3. Japan Cholesterol Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Test Type
8.3.3.2.3. By Prescription Mode
8.3.3.2.4. By End User
8.3.4. South Korea Cholesterol Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Test Type
8.3.4.2.3. By Prescription Mode
8.3.4.2.4. By End User
8.3.5. Australia Cholesterol Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Test Type
8.3.5.2.3. By Prescription Mode
8.3.5.2.4. By End User
9. South America Cholesterol Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Test Type
9.2.3. By Prescription Mode
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cholesterol Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Test Type
9.3.1.2.3. By Prescription Mode
9.3.1.2.4. By End User
9.3.2. Argentina Cholesterol Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Test Type
9.3.2.2.3. By Prescription Mode
9.3.2.2.4. By End User
9.3.3. Colombia Cholesterol Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Test Type
9.3.3.2.3. By Prescription Mode
9.3.3.2.4. By End User
10. Middle East and Africa Cholesterol Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Test Type
10.2.3. By Prescription Mode
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cholesterol Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Test Type
10.3.1.2.3. By Prescription Mode
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Cholesterol Testing Market Outlook
